Acute Limb Ischemia and Rutherford Classification: Scoping Review with ☸️SAIMSARA
SAIMSARA Journal · 29.03.2026 · 1 (1)
DOI: 10.62487/saimsara0aca7d8d ↗Kurz gefasst
Scoping Review in der Zeitschrift SAIMSARA Journal, online erschienen am 29.03.2026. Die Arbeit nennt 63 Literaturangaben.
Abstract (Originalsprache)
The aim of this paper is to synthesize contemporary evidence regarding the prognostic utility of the Rutherford classification in patients with ALI, evaluating its role in predicting limb salvage, mortality, and the efficacy of various surgical and endovascular management strategies. The review utilises 275 original studies with 841948 total participants (topic deduplicated ΣN). The evidence map consistently indicates that Rutherford class is one of the strongest clinical signals for prognosis in acute limb ischemia, with higher stages associated with worse limb salvage and survival; reported limb salvage remained high in lower classes at a median 92.5% (range 79.2%–98.2%), whereas Rutherford III was associated with salvage of 8% and mortality of 15%. Across the mapped studies, Rutherford IIb emerged as the key practical threshold, identifying limbs at immediate risk, aligning with higher odds of death or amputation, and marking patients more vulnerable to reperfusion-related compartment syndrome. The broader literature also suggests that Rutherford staging remains clinically useful for selecting revascularization strategy, with strong short-term results reported for endovascular and mechanical thrombectomy approaches in Rutherford I–IIb disease, while delayed presentation within the same severity stratum still worsens outcomes. At the same time, the mapped evidence is heterogeneous and largely observational, so these signals should be interpreted as consistent patterns rather than definitive comparative proof. In practice, the review supports using Rutherford classification as a bedside triage and prognostic framework to accelerate intervention, guide fasciotomy vigilance, and contextualize adjuncts such as CTA and biomarker-based risk models. Future research should focus on prospective, standardized Rutherford-stratified studies that compare treatment pathways within the same severity classes and test whether adding imaging or biomarker data improves prediction beyond clinical staging alone.
Zitieren
APA
(2026). Acute Limb Ischemia and Rutherford Classification: Scoping Review with ☸️SAIMSARA. SAIMSARA Journal, 1(1). https://doi.org/10.62487/saimsara0aca7d8d
Vancouver
Acute Limb Ischemia and Rutherford Classification: Scoping Review with ☸️SAIMSARA. SAIMSARA Journal. 2026;1(1). doi:10.62487/saimsara0aca7d8d
BibTeX
@article{euvimed2026,
title = {Acute Limb Ischemia and Rutherford Classification: Scoping Review with ☸️SAIMSARA},
journal = {SAIMSARA Journal},
year = {2026},
volume = {1},
number = {1},
doi = {10.62487/saimsara0aca7d8d}
}
EUVIMED